Question 1

What is the catalog number for 3-Fluoro-5-morpholino-1-bromobenzene?

Accepted Answer

The catalog number for 3-Fluoro-5-morpholino-1-bromobenzene is 425736.

Question 2

What sizes are available for 3-Fluoro-5-morpholino-1-bromobenzene?

Accepted Answer

3-Fluoro-5-morpholino-1-bromobenzene is available in the following size(s): 100 mg, 250 mg.

Question 3

How many pack sizes does 3-Fluoro-5-morpholino-1-bromobenzene come in?

Accepted Answer

3-Fluoro-5-morpholino-1-bromobenzene is available in 2 different pack sizes.

Question 4

Is 3-Fluoro-5-morpholino-1-bromobenzene in stock?

Accepted Answer

3-Fluoro-5-morpholino-1-bromobenzene is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 7

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

3-Fluoro-5-morpholino-1-bromobenzene

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

UFM1 Rabbit Polyclonal Antibody

Human MBL2 Recombinant Rabbit Monoclonal Antibody [PSH04-86] - BSA and Azide free (Detector)

FNBP1L antibody

TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) (TIGIT/3017), CF647 conjugate, 0.1mg/mL

DMT1 (SLC11A2) (NM_000617) Human Over-expression Lysate

Lin28B Mouse Monoclonal Antibody [A2-4-5]